|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00232128 |
|
Date of registration:
|
03/10/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
|
|
Scientific title:
|
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms |
|
Date of first enrolment:
|
June 2003 |
|
Target sample size:
|
|
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT00232128 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Marshall T. Schreeder, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Comprehensive Cancer Institute |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria: The patients enrolled in this study should be judged to have
sufficient survival to benefit from control of local disease and include at least one of
the following:
1. unresectable primary or metastatic lung tumors
2. may benefit from multiple modalities of therapy
3. chemotherapeutic or radiation oncologic options have been exhausted
Exclusion Criteria:
1. co-existing morbidities that preclude the use of surgery
Age minimum:
19 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Pulmonary Neoplasms
|
|
Intervention(s)
|
|
Procedure: Radiofrequency Ablation of pulmonary neoplasms
|
|
Secondary ID(s)
|
|
CCI LUN 02
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|